ライフサイエンスコーパス: nasal discharge

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 se/ocular chlamydial positivity and positive nasal discharge.

2 e 1128 children participating, 188 (17%) had nasal discharge.

3 ed from several domestic cats with bilateral nasal discharge.

4 s of cough (2.1 vs. 5.0 days; P < .0001) and nasal discharge (3.0 vs. 4.5 days, P = .02) Blinding of

5 to 4.1] vs. 6.3 [CI, 4.9 to 7.7] days), and nasal discharge (4.1 [CI, 3.3 to 4.9] vs. 5.8 [CI, 4.3 t

6 Among 188 children with nasal discharge, 64 (34%) nasal swabs were PCR positive.

7 ween Chlamydia trachomatis Amplicor-positive nasal discharge and Amplicor-positive ocular swabs was i

8 Clinically, inoculated pigs had nasal discharge and fever and shed virus through nasal s

9 ted red deer had lethargy, ocular signs, and nasal discharge and were euthanatized within 48 h.

10 oms after vaccination were nasal stuffiness, nasal discharge, and sneezing.

11 1; 95% confidence interval [CI], 1.14-4.67), nasal discharge (aOR, 4.57; 95% CI, 1.30-16.10), and str

12 than were children without Amplicor-positive nasal discharge at baseline (95% CI: 1.54-17.23), after

13 Children with positive nasal discharge at baseline were 5.2 times more likely t

14 to a plastic toy fomite soaked with infected nasal discharge from the treatment calves.

15 Children with visible nasal discharge had swabs taken of this material.

16 clothes and back to the eye; alternatively, nasal discharge may be an indicator of severe persistent

17 Nasal discharge may provide a source of reinfection with

18 Subjective symptom scores for sore throat, nasal discharge, nasal congestion, sneezing, cough, scra

19 A history of fever, a history of cough, and nasal discharge noted on examination were each associate

20 r more than 10 days, high fever and purulent nasal discharge or facial pain lasting for at least 3 co

21 s of high fever (>39 degrees C) and purulent nasal discharge or facial pain lasting for at least 3 co

22 arge (OR 0.40, 95% CI 0.31-0.49) and lack of nasal discharge (OR 0.56, 95% CI 0.37-0.76).

23 arge (OR 0.42, 95% CI 0.23-0.61) and lack of nasal discharge (OR 0.62, 95% CI 0.52-0.72).

24 infection to severe weight loss, ocular and nasal discharge, sneezing, and lethargy.

25 exercise test was positive accompanied with nasal discharge, sneezing, throat discomfort, swelling o

26 Ipratropium recipients had 26% less nasal discharge than controls (P = 0.0024) and 34% less

27 arge than controls (P = 0.0024) and 34% less nasal discharge than untreated patients (P = 0.0001).

28 times more likely to have Amplicor-positive nasal discharge than were children without ocular positi

29 to characterize the associations of IAD and nasal discharge with viral and bacterial infections.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。